Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move 2023-12-20 23:10
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum 2023-12-20 20:00
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs 2023-12-20 09:00
Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case 2023-12-19 22:00
New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA 2023-12-19 20:00
Tianjin's Youthful Energy Sparks Citywide Revival 2023-12-19 15:44
Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide 2023-12-18 22:00
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome 2023-12-18 19:00
NUS researchers develop an innovative and flexible method to study immune cell capabilities 2023-12-18 14:47
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 2023-12-18 09:49
GeneQuantum and BioMap establish a strategic collaboration to jointly develop a series of next-generation ADC therapeutics 2023-12-18 09:43
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM 2023-12-17 23:15
Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction 2023-12-16 15:47
SeekIn and OncoInv Collaborate to Expand the Global Accessibility of Multiple Cancer Detection Tests and Bridge Global Disparities in Cancer Care 2023-12-15 21:00
Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023 2023-12-15 21:00
Live from ASH 2023 | Oral Report Featuring Encouraging Data of Olverembatinib Combined with Reduced-Intensity Chemotherapy in Patients with Ph+ ALL Presented at the ASH Annual Meeting 2023-12-15 11:14
Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC) 2023-12-15 07:30
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed 2023-12-14 22:05
China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement 2023-12-14 21:30
Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT 2023-12-14 20:34
1 46 47 48 49 50 431